Metropolitan Life Insurance Company (MetLife)’s Concentrix CNXC Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio CNXC Stock Details CNXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-7,661	Closed	-$1.37M	–	2336
2021 Q4	$1.37M	Sell	7,661 -143	-2%	-$25.5K	0.02%	743
2021 Q3	$1.38M	Sell	7,804 -75	-1%	-$12.4K	0.02%	735
2021 Q2	$1.27M	Buy	7,879 +16	+0.2%	+$2.46K	0.02%	828
2021 Q1	$1.18M	Buy	7,863 +470	+6%	+$57K	0.02%	835
2020 Q4	$730K	Buy	+7,393	New	+$739K	0.01%	1103

Other funds holding CNXC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s CNXC Position: Q1 2022 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Concentrix (CNXC) in Q1 2022, closing a stake of 7,661 shares — an estimated $1.37M sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in CNXC in Q4 2020 and held it in 5 quarters. The position peaked at $1.38M in Q3 2021. 354 funds tracked by Wall St. Rank hold CNXC as of Q1 2022.

Metropolitan Life Insurance Company (MetLife) reported no remaining Concentrix position as of Q1 2022 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 7,661 Concentrix shares in Q1 2022, an estimated $1.37M.
Metropolitan Life Insurance Company (MetLife) first reported a position in Concentrix in Q4 2020 and held it in 5 quarters.
Metropolitan Life Insurance Company (MetLife)'s Concentrix position peaked at $1.38M in Q3 2021.
354 funds tracked by Wall St. Rank held Concentrix as of Q1 2022.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2022, filed 12 May 2022.